当前位置: X-MOL 学术Crit. Care Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Position Paper on the Reporting of Norepinephrine Formulations in Critical Care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force.
Critical Care Medicine ( IF 8.8 ) Pub Date : 2024-01-19 , DOI: 10.1097/ccm.0000000000006176
Patrick M. Wieruszewski 1, 2 , Marc Leone 3 , Benjamin Skov Kaas-Hansen 4 , Siddharth Dugar 5, 6 , Matthieu Legrand 7 , Cathrine A. McKenzie 8 , Brittany D. Bissell Turpin 9, 10 , Antonio Messina 11, 12 , Prashant Nasa 13 , Christa A. Schorr 14, 15 , Jan J. De Waele 16, 17 , Ashish K. Khanna 18, 19
Affiliation  

To provide guidance on the reporting of norepinephrine formulation labeling, reporting in publications, and use in clinical practice.

中文翻译:

重症监护医学会和欧洲重症监护医学会联合工作组关于重症监护中去甲肾上腺素制剂报告的立场文件。

为去甲肾上腺素制剂标签的报告、出版物中的报告以及临床实践中的使用提供指导。
更新日期:2024-01-19
down
wechat
bug